Rayon Ivd Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 11-12-2024
- Paid Up Capital ₹ 5.00 M
as on 11-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
as on 11-12-2024
- Satisfied Charges ₹ 7.20 M
as on 11-12-2024
- Revenue 9.82%
(FY 2021)
- Profit 7.24%
(FY 2021)
- Ebitda 7.46%
(FY 2021)
- Net Worth 22.70%
(FY 2021)
- Total Assets 124.69%
(FY 2021)
About Rayon Ivd
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.25 Cr. The company has closed loans amounting to ₹7.20 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rayon Ivd Private Limited India is Dronamraju Murthy as CEO. Dronamraju Murthy and Vamsi Sakammagari serve as directors at the Company.
- CIN/LLPIN
U33309TG2014PTC093193
- Company No.
093193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rayon Ivd?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dronamraju Murthy  | Managing Director | 26-Feb-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vamsi Sakammagari | Additional Director | 22-Feb-2024 | Current |
Financial Performance of Rayon Ivd.
Rayon Ivd Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 9.82% increase. The company also saw a slight improvement in profitability, with a 7.24% increase in profit. The company's net worth Soared by an impressive increase of 22.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rayon Ivd?
In 2021, Rayon Ivd had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2023 | ₹1.25 Cr | Open |
Others Creation Date: 21 Jul 2018 | ₹2.50 M | Satisfied |
Vijaya Bank Creation Date: 15 Apr 2015 | ₹4.70 M | Satisfied |
How Many Employees Work at Rayon Ivd?
Unlock and access historical data on people associated with Rayon Ivd, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rayon Ivd, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayon Ivd's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
